People world over are getting increasingly edgy with reports on fast-spreading corona continue to flood them. It is important to look at some positive inputs, though they are only a few, to stay bold and hopeful in this dark phase.
Total cases: A total of 858,669 cases as of this morning, with 42,151 deaths in 197 countries
More people recover: As many as 178,099 people recovered, which means around 12000 more survived the deadly disease in the last 24 hours.
Mostly mild cases: 605,521(95%) of the total active cases are still in mild condition.
Global Recovery: China has reported 76,206 recoveries, according to John Hopkins tracker. It says, 19,259 in Spain, 16,100 in Germany, 15,729 in Italy, 14,656 in Iran, 9522 in France and 7109 in US also recovered.
Indian cases: 1238 active cases, 123 cured and discharged and 35 deaths, according to the Union Health Ministry. As many as 15,24,266 people have been screened at the airports.
Europe: The only good news coming from Europe is that the spread of infections is slowing down in the worst-hit countries like Italy and Spain, though still the number of deaths continues unabated. France and Britain also reported large number of deaths.
Anti-malaria drugs: The US FDA gave doctors the go-ahead to try two anti-malaria drugs –chloroquine phosphate and hydroxychloroquine sulfate—to treat corona-hit people. The Department of Health and Human Services (HHS) says drugmakers have donated 30 million doses of hydroxychloroquine sulfate and 1 million doses of chloroquine phosphate to the strategic national stockpile.
Corona vaccine: Drug maker Johnson & Johnson human clinical trials for a COVID-19 vaccine will start by September. In March, the National Institutes of Health started a phase 1 trial for a vaccine called mRNA-1273. It was developed by federal scientists and the biotechnology company Moderna Inc., Johnson & Johnson says it is working with the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services. The company and BARDA have pledged $1 billion for vaccine research, development and clinical testing.
Rs 100 cr from Mittal: Billionaire Lakshmi N Mittal will give Rs 100 crore to the PM CARES Fund. “Both our operations in India commit equally to a total of Rs 100 crore to PM-CARES for the ongoing relief efforts countrywide,” Mittal said in a statement.